Georgia's Online Cancer Information Center

Find A Treatment Site

Atrium Health Navicent

The Peyton Anderson Cancer Center is a building located at 800 First Street, Macon, Georgia. The Services provided in the building are part of Atrium Health Navicent or they are private practitioners.

Visitors will find warm, friendly staff providing patient focused care.

At Atrium Health Navicent Everything about us is all about you.

Among the services you will find at The Peyton Anderson Cancer Center, Atrium Health Navicent are:

  • General Number                                                                            (478) 633-3000
  • PET/CT Center, Atrium Health Navicent                                        (478) 633-4738
  • Breast Care Center, Atrium Health Navicent                                 (478) 633-7020
  • Central Georgia Cancer Care                                                        (478) 743-7068
  • Infusion Services, Atrium Health Navicent                                    (478) 633-8811
  • Central Georgia Radiation Oncology                              &nbs

Treatment Sites in Georgia

Primary Location

Oncology Research, Atrium Health Navicent
777 Hemlock Street, MSC 123
(PACC 800 1st St, Ste 250)
Macon, GA 31201
478-633-3000 (p)
478-633-8894 (f)
www.Atriumhealth.org

driving directions


Central Georgia Cancer Care

800 First Street
Suite 410
Macon, 31201
478 633-2152 (p)
(478) 633-8894 (f)


driving directions

Clinical Trials in Georgia

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
Cancer Type: Unspecified
Study Coordinator: Oncology Research Nurse - 4786332152


A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Cancer Type: Germ Cell Tumor
Study Coordinator: Oncology Research Nurse - 4786332152


A Phase 3 Trial Investigating Blinatumomab ( NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)
Cancer Type: Lymphoma
Study Coordinator: Oncology Research Nurse - 4786332152


A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Placebo for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Cancer Type: Lung Cancer
Study Coordinator: Oncology Research Nurse - (478) 633-2152


A Randomised Phase 3 Trial of Accelerated versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumours
Cancer Type: Germ Cell Tumor, Ovarian Cancer
Study Coordinator: Oncology Research Nurse - 4786332152


A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) versus VAC/VI plus Temsirolimus (TORI, Torisel, NSC# 683864, IND#122782) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
Cancer Type: Bone and Soft Tissue (including Sarcoma), Rhabdomyosarcoma
Study Coordinator: Oncology Research Nurse - 4786332152


A Randomized Web-Based Physical Activity Intervention among Children and Adolescents with Acute Lymphoblastic Leukemia
Cancer Type: Unspecified
Study Coordinator: Oncology Research Nurse - 4786332152


Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Cancer Type: Lung Cancer
Study Coordinator: Oncology Research Nurse - (478)633-2152


EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
Cancer Type: Eye Cancer, Lymphoma, Multiple Primaries, Non-Hodgkin Lymphoma, Solid Tumor, Unknown Primary
Study Coordinator: Oncology Research Nurse - 4786332152


International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbones
Cancer Type: Lymphoma
Study Coordinator: Oncology Research Nurse - 4786332152


The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Cancer Type: Eye Cancer, Non-Hodgkin Lymphoma, Unknown Primary
Study Coordinator: Oncology Research Nurse - 4786332152
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.